Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00745355 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Quality of Life in Patients With Bladder Cancer

StatusActive, Not Recruiting
PhaseNot specified
Started2008-08
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Aug 2026 → Aug 2027
See other at-risk trials from Memorial Sloan Kettering Cancer Center

Amendment history

2026-09-26
Primary completion pushed: 2026-08 → 2027-08
Completion pushed: 2026-08 → 2027-08
2026-05-29
3 amendments v33-v35
3 re-verifications since 2024-05-28, no change to tracked fields
2023-05-26
Study Status v32
Primary completion date2023-08→2026-08
Completion date2023-08→2026-08
2022-12-08
Study Status, Sponsor/Collaborators v31
Collaborators4 to 5 entries
Lahey Hospital & Medical Center
2022-09-01
Study Status v30
Primary completion date2022-08→2023-08
Completion date2022-08→2023-08
Show 29 earlier versions
2021-11-02
Study Status v29
Re-verified, no change to tracked fields
2021-09-22
Study Status v28
Primary completion date2021-08→2022-08
Completion date2021-08→2022-08
2020-09-21
Study Status v27
Primary completion date2020-08→2021-08
Completion date2020-08→2021-08
2020-06-26
Study Status, Document Section v26
Re-verified, no change to tracked fields
2019-09-06
Study Status v25
Primary completion date2019-08→2020-08
Completion date2019-08→2020-08
2018-09-05
Study Status v24
Primary completion date2018-08→2019-08
Completion date2018-08→2019-08
2017-09-05
Study Status v23
Primary completion date2017-08→2018-08
Completion date2017-08→2018-08
2016-11-07
Study Status, Sponsor/Collaborators v22
Collaborators3 to 4 entries
DeltaQuest Foundation, Inc.
2016-09-26
Study Status v21
Primary completion date2016-08→2017-08
Completion date2016-08→2017-08
2015-09-25
Study Status, Eligibility v20
Re-verified, no change to tracked fields
2015-09-21
Study Status v19
Primary completion date2015-08→2016-08
Completion date2015-08→2016-08
2014-10-15
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v18
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 1 of 1 site
2014-09-11
Study Status v17
Re-verified, no change to tracked fields
2014-08-14
Study Status, Sponsor/Collaborators v16
Collaborators2 to 3 entries
Lenox Hill Hospital
2014-04-09
Study Status v15
Primary completion date2014-08→2015-08
Completion date2014-08→2015-08
2013-11-14
2 amendments v13-v14
2 re-verifications since 2013-08-14, no change to tracked fields
2013-05-16
Study Status, Study Design v12
Primary completion date2013-08→2014-08
Completion date2013-08→2014-08
Enrollment target400→550
2013-01-24
Study Status, Sponsor/Collaborators v11
Collaborators1 to 2 entries
Northwell Health
2012-10-18
Study Status v10
Re-verified, no change to tracked fields
2012-03-13
Study Status, Study Design v9
Primary completion date2012-08→2013-08
Completion date2012-08→2013-08
Enrollment target300→400
2012-01-05
Study Status, Sponsor/Collaborators v8
Primary completion date2011-08→2012-08
Completion date2011-08→2012-08
2011-06-30
3 amendments v5-v7
3 re-verifications since 2010-12-16, no change to tracked fields
2010-06-21
Study Status, Contacts/Locations v4
Study sitescontacts updated at 1 of 1 site
2009-12-14
Study Identification, Study Status, Study Description, Arms and Interventions, Eligibility v3
Eligibility criteria-58 characters
Inclusion Criteria: All patients (male and female) who are diagnosed with invasive bladder cancer Patients and/ormust arebe scheduled for radical cystectomy and urinary diversion are eligibleand/or being evaluated for participationneo-adjuvant inchemotherapy theprior studyto a planned cystectomy. Participants must be able to speak English. Participants m [...] t. Participants must be 18 years of age or older to enroll. Participants must be diagnosed with invasive bladder cancer and scheduled for radical cystectomy. Participant may be eligible for and may receive neoadjuvant [...]
Study title-9 characters
Quality of Life in Patients With Invasive Bladder Cancer
2009-06-15
Study Status, Sponsor/Collaborators, Contacts/Locations v2
Study sitescontacts updated at 1 of 1 site
Collaborators+35 characters
Albert Einstein College of Medicine
2009-02-02
Study Status v1
Re-verified, no change to tracked fields
2008-09-02
Original filing
The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.
Trial Details
NCT Number NCT00745355
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Albert Einstein College of Medicine, Northwell Health, Lenox Hill Hospital, DeltaQuest Foundation, Inc., Lahey Hospital & Medical Center
Conditions Bladder Cancer
Enrollment 550 participants
Start Date 2008-08
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-09-25